GC
VIVO

Globeflex Capital’s Meridian Bioscience Inc VIVO Stock Holding History

Globeflex Capital’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-98,041
Closed -$2.98M – 546
2022
Q2 		$2.98M Buy
98,041
+25,033
+34% +$677K 0.73% 26
2022
Q1 		$1.9M Hold
73,008
– – 0.38% 60
2021
Q4 		$1.49M Hold
73,008
– – 0.3% 92
2021
Q3 		$1.41M Sell
73,008
-112,931
-61% -$2.25M 0.31% 87
2021
Q2 		$4.12M Buy
185,939
+27,275
+17% +$579K 0.74% 14
2021
Q1 		$4.17M Hold
158,664
– – 0.76% 16
2020
Q4 		$2.96M Buy
158,664
+6,524
+4% +$122K 0.63% 26
2020
Q3 		$2.58M Buy
152,140
+11,320
+8% +$220K 0.68% 16
2020
Q2 		$3.28M Buy
140,820
+61,961
+79% +$898K 0.83% 10
2020
Q1 		$662K Buy
+78,859
New +$664K 0.2% 172

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Globeflex Capital's VIVO Position: Q3 2022 in Review

Globeflex Capital sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 98,041 shares — an estimated $2.98M sold.

Globeflex Capital first reported a position in VIVO in Q1 2020 and held it in 10 quarters. The position peaked at $4.17M in Q1 2021. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • Globeflex Capital reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • Globeflex Capital sold 98,041 Meridian Bioscience Inc shares in Q3 2022, an estimated $2.98M.
  • Globeflex Capital first reported a position in Meridian Bioscience Inc in Q1 2020 and held it in 10 quarters.
  • Globeflex Capital's Meridian Bioscience Inc position peaked at $4.17M in Q1 2021.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on Globeflex Capital's 13F filing for Q3 2022, filed 14 Nov 2022.